Scinai Immunotherapeutics Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel.
Scinai Immunotherapeutics stock last closed at $2.22, down 4.72% from the previous day, and has decreased 21.28% in one year. It has overperformed other stocks in the Biotechnology industry by 0.55 percentage points. Scinai Immunotherapeutics stock is currently +16.84% from its 52-week low of $1.90, and -75.11% from its 52-week high of $8.92.
There are currently 3.41B shares of SCNI outstanding. The market cap of SCNI is $0.00. In the past 24 hours, 55,000 SCNI shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy SCNI shares.
Based on our research, eToro is the best brokerage. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you'll need to fill out some personal info so you can invest in SCNI stock today.
Now that you've opened your account on the best investment app, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing money into your new brokerage account.
After you have selected the best place to buy Scinai Immunotherapeutics stock, it's critical to analyze their stock before you invest, so you actually understand the risk as well as the upside.
WallStreetZen was built to help average investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SCNI's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SCNI's fair value.
You can do additional valuation research on SCNI's stock here.
Last year, SCNI earnings were -$4.80M. During the past 2 year, SCNI's earnings have increased by -100% per year. This was slower than the Biotechnology industry average of 8.66%.
Dig into SCNI's earnings and revenue performance here.
Over the past 12 months, insiders at SCNI have not bought or sold any shares.
Learn more about who owns SCNI stock here.
No, Scinai Immunotherapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two primary types of orders:
Press the Open button and eToro will execute your order.
If you want additional help with buying stocks on eToro, watch the how to video below:
Now that you own some shares in SCNI, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to keep tabs on your SCNI stock.
To summarize, here are the 6 steps to buy Scinai Immunotherapeutics stock:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Scinai Immunotherapeutics, add SCNI to your watchlist below.